9. Greenberg SA. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007;69:2008-19. 10. Banwell BL, Engel AG. AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 2000;54:1033-41. 11. Fukuchi K, Pham D, Hart M, Li L, Lindsey JR. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. Am J Pathol 1998;153:1687-93. 12. Salajegheh M, Pinkus JL, Nazareno R, Amato AA, Parker KC, Greenberg SA. Nature of “Tau” immunoreactivity in normal myonuclei and inclusion bodymyositis. Muscle Nerve 2009;40:520-8.
Drs. Wan, Liang, and Greenlund are with the Department of Internal Medicine in the Mayo Clinic in Rochester, Minnesota.
J La State Med Soc VOL 166 November/December 2014 257
Made with FlippingBook - Online catalogs